Latest Breaking News On - Committee for medicinal products human - Page 6 : vimarsana.com

Kalydeco approved in EU for CF children as young as 1 month

Kalydeco approved in EU for CF children as young as 1 month
cysticfibrosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cysticfibrosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Czech republicCarmen bozicEuropean commissionEuropean unionEuropean medicines agencyVertex pharmaceuticalsCommittee for medicinal products humanMedicinal productsHuman useEuropean medicines

Idorsia Pharmaceuticals Ltd: JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension

Idorsia Pharmaceuticals Ltd: JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalDennis riedlJ physiol pharmacolClozelm aprocitentanAndrewc weissJean paul clozelIdorsia ltdEuropean commissionHead of investor relations corporate communicationsSwiss exchangeEuropean union member statesIdorsia pharmaceuticals ltdCommittee for medicinal products humanEuropean medicines agencyCommittee for medicinal products human use

JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension

Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ as the first and only endothelin receptor.

Switzerland generalUnited statesJean paul clozelClozelm aprocitentanJ physiol pharmacolAndrewc weissEuropean medicines agencyEuropean commissionEuropean unionCommittee for medicinal products human useSwiss exchangeDrug administrationEuropean union member statesIdorsia ltdIdorsia pharmaceuticals ltdCommittee for medicinal products human

JERAYGO (Aprocitentan) Recommended For Approval In Europe For The Treatment Of Resistant Hypertension

(MENAFN - GlobeNewsWire - Nasdaq) Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGOTM . .

Committee for medicinal products humanMedicinal productsHuman useCom finance health marketing menafn pharmaceuticals

AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab

AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarc dunoyerHubert schrezenmeierCommittee for medicinal products humanUniversity of ulmDrug administrationEuropean medicines agencyEuropean unionEuropean commissionInstitute of transfusion medicineMedicinal productsHuman useLancet haematologyMedical directorTransfusion medicineChief executive officer